97.40
+3.00
+(3.18%)
At close: April 17 at 8:08:26 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
17,619,000
17,619,000
14,458,000
14,236,000
15,071,000
Investing Cash Flow
-7,513,000
-7,513,000
5,596,000
1,468,000
4,208,000
Financing Cash Flow
-11,742,000
-11,742,000
-14,278,000
-20,562,000
-16,264,000
End Cash Position
11,459,000
11,459,000
13,393,000
7,517,000
12,407,000
Capital Expenditure
-3,814,000
-3,814,000
-2,753,000
-2,239,000
-2,556,000
Issuance of Debt
7,101,000
7,101,000
546,000
252,000
16,000
Repayment of Debt
-2,711,000
-2,711,000
-2,481,000
-2,837,000
-5,987,000
Repurchase of Capital Stock
-8,331,000
-8,331,000
-8,719,000
-10,652,000
-3,057,000
Free Cash Flow
13,805,000
13,805,000
11,705,000
11,997,000
12,515,000
12/31/2021 - 3/8/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
D4S.MU Daiichi Sankyo Co Ltd
19.26
-0.98%
BRM.MU Bristol-Myers Squibb Co
43.73
-0.08%
SNW.HM Sanofi SA
90.38
+0.33%
4AB.F AbbVie Inc.
152.60
-0.13%
MRK.MX Merck & Co., Inc.
1,560.00
-2.80%
PFE.CL Pfizer Inc.
95,280.00
-2.60%
PNVL3.SA Dimed S.A. Distribuidora de Medicamentos
8.90
+1.60%
BAYZF Bayer Aktiengesellschaft
23.91
0.00%
0R34.IL Johnson & Johnson
157.90
+1.81%
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,909.25
-0.66%